Orfit Pharmaceutical Pvt. Ltd. | Trusted Pharma Products & Healthcare Solutions
background

EDIPASS-DS Capsules

EDIPASS-DS Capsules

EDIPASS-DS Capsules

EDIPASS-DS Capsules is a high-strength anti-inflammatory and anti-edematous enzyme formulation from Orfit Pharmaceutical Pvt. Ltd., developed to provide effective management of pain, swelling, and tissue inflammation. It contains a potent combination of Trypsin 96 mg, Bromelain 180 mg, and Rutoside Trihydrate 200 mg, which work synergistically to reduce edema, improve circulation, and accelerate the body’s natural healing process. This advanced enzyme therapy is commonly used in conditions such as post-surgical swelling, soft-tissue injuries, sports trauma, dental procedures, orthopedic conditions, and inflammatory disorders. Trypsin and bromelain help break down inflammatory mediators and promote faster tissue repair, while rutoside strengthens capillary walls and reduces fluid leakage, resulting in effective control of pain and swelling without causing gastric irritation. EDIPASS-DS Capsules are especially beneficial in moderate to severe inflammatory conditions where higher enzyme strength is required for faster recovery and improved mobility. Manufactured under stringent quality and safety standards, EDIPASS-DS reflects Orfit Pharmaceutical Pvt. Ltd.’s commitment to delivering reliable, effective, and patient-focused solutions for inflammation control and enhanced healing.